Valuation : Amarin Corporation plc

Market Cap 290M 249M 234M 214M 399M 27.38B 402M 2.77B 1.08B 13.99B 1.09B 1.06B 45.06B P/E 2026 *
-196x
P/E 2027 * -229x
Enterprise Value 127M 110M 103M 94.05M 176M 12.04B 177M 1.22B 474M 6.15B 478M 468M 19.81B EV / Sales 2026 *
0.72x
EV / Sales 2027 * 0.65x
Free-Float
86.93%
Yield 2026 *
-
Yield 2027 * -
1 day+0.07%
1 week-2.56%
Current month-1.22%
1 month-3.04%
3 months-5.64%
6 months-4.46%
Current year-1.76%
1 week 13.6
Extreme 13.6
14.32
1 month 13.6
Extreme 13.6
15.24
Current year 12.96
Extreme 12.96
17.31
1 year 12.96
Extreme 12.96
20.9
3 years 7.08
Extreme 7.08
27.4
5 years 7.08
Extreme 7.08
110.4
10 years 7.08
Extreme 7.08
522.4
Manager TitleAgeSince
Chief Executive Officer 63 2024-06-03
Director of Finance/CFO 42 2024-10-22
Compliance Officer 56 2023-11-14
Director TitleAgeSince
Director/Board Member 63 2024-06-03
Director/Board Member 43 2023-02-27
Director/Board Member 67 2023-02-27
Date Insider Type Main position Quantity % Market Cap. Importance
8/1/26 Exercice

Chief Financial Officer

781 0.0002%
7/1/26 Exercice

Chief Operating Officer

9,302 0.0022%
7/1/26 Exercice

Chief Technology Officer

9,263 0.0022%
Change 5-day change 1-year change 3-year change Capi.($)
+0.07%-2.56%-8.84%-35.33% 290M
+0.41%-2.07%+41.26%+95.40% 69.02B
-0.88%+1.03%+43.24%+90.44% 66.32B
+0.04%+4.36%-11.72%+459.54% 27.66B
-0.90%-7.65%+2.45%-15.50% 25.84B
-3.00%-2.90%+39.40%+9.41% 26.54B
0.00%+1.86%+25.85%-17.54% 20.4B
+3.45%-13.46%+222.69%+389.50% 17.63B
-1.49%-4.88%-0.41%+530.26% 15.15B
+1.03%+7.00%+59.98%+160.03% 14.65B
Average -0.13%-1.49%+41.39%+166.62% 28.35B
Weighted average by Cap. -0.28%-0.83%+41.71%+148.22%

Financials

2026 *2027 *
Net sales 177M 153M 143M 131M 245M 16.77B 247M 1.69B 660M 8.57B 666M 652M 27.61B 177M 152M 143M 131M 244M 16.72B 246M 1.69B 658M 8.54B 664M 650M 27.51B
Net income -26.62M -22.91M -21.5M -19.67M -36.71M -2.52B -37M -254M -99.03M -1.29B -99.98M -97.8M -4.14B -18.32M -15.76M -14.79M -13.53M -25.26M -1.73B -25.46M -175M -68.14M -885M -68.79M -67.29M -2.85B
Net Debt -162M -140M -131M -120M -224M -15.34B -226M -1.55B -604M -7.84B -609M -596M -25.25B -175M -150M -141M -129M -241M -16.53B -243M -1.67B -651M -8.45B -657M -642M -27.21B
Logo Amarin Corporation plc
Amarin Corporation PLC is a pharmaceutical company. The Company is focused on the commercialization and development of therapeutics to improve cardiovascular (CV), health and reduce CV risk. The Company operates through the development and commercialization of VASCEPA. Its lead product, Vascepa (icosapent ethyl) capsule is used as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. This indication for Vascepa, known as the MARINE indication, is based primarily on the results from the MARINE study of Vascepa in this approved patient population. The Company sells Vascepa principally to wholesalers, as well as selected regional wholesalers and specialty pharmacy providers, or collectively, its distributors, which in turn resell Vascepa to retail pharmacies for resale to patients and healthcare providers.
Employees
80
Date Price Change Volume
26-09-03 $13.71 +0.07% 48,444
26-09-02 $13.70 -1.05% 45,612
26-09-01 $13.85 -0.25% 39,937
26-08-31 $13.88 -0.64% 40,870
26-08-28 $13.97 -0.71% 78,195
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
SELL
Number of Analysts
2
Last Close Price
13.71USD
Average target price
12.50USD
Spread / Average Target
-8.83%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. AMRN Stock